EditorialCreativeSportsCollectionsVideos
Prices
0Log in

Visual content for professionals.
800M+ images and videos.

Content Hub

  • Current Events
  • Pictures of the Year
  • Sports
  • Editorial
  • Creative
  • Collections
  • Videos

Offers

  • Prices & Packages
  • Promotions
  • Enterprise
  • Newsletter
  • Blog
  • The Game Magazine

Services

  • Content Research
  • Contract Photography
  • API & FTP Push
  • my-picturemaxx
  • Become a Partner

Company

  • About IMAGO
  • Careers
  • News

Help Center

  • FAQ
  • Contact Us
Legal NoticeTerms & ConditionsLicense InformationData PrivacyPrivacy Settings
© 2026 IMAGO
CEPICBAPLABVPA
  3. Coronavirus, Novartis stops hydroxychloroquine study due to lack of participants

Coronavirus, Novartis stops hydroxychloroquine study due to lack of participants

Jun 21, 2020

The following photos have been selected for you by the IMAGO picture desk on this topic. For more pictures please use the search function.

Images in this collection

  • 12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

    12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

  • 12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

    12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

  • 12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

    12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

  • 12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

    12 02 2020 Basel ,Switzerland In the picture Novartis high-rise logo lettering, real estate chemical industry

  • 11 03 2020 Basel , SWITZERLAND , Novartis pharmaceutical company in Basel

    11 03 2020 Basel , SWITZERLAND , Novartis pharmaceutical company in Basel

  • 11 03 2020 Basel , SWITZERLAND , Novartis pharmaceutical company in Basel

    11 03 2020 Basel , SWITZERLAND , Novartis pharmaceutical company in Basel

  • 11 03 2020 Basel , SWITZERLAND , Chemical company BASF and pharmaceutical company Novartis in Basel

    11 03 2020 Basel , SWITZERLAND , Chemical company BASF and pharmaceutical company Novartis in Basel

  • 28 09 2018 Basel Pictured Novartin factory layoff layoffs factory chemical factory logo lettering

    28 09 2018 Basel Pictured Novartin factory layoff layoffs factory chemical factory logo lettering

  • 28 09 2018 Basel Pictured Novartin factory layoff layoffs factory chemical factory logo lettering

    28 09 2018 Basel Pictured Novartin factory layoff layoffs factory chemical factory logo lettering

  • Unternehmen: Novartis Schweiz, Basel, 05.09.2014 Top 10 der umsatzstärksten Pharmaunternehmen weltweit Das Schweizer Unternehmen Novartis war im vergangenen Jahr an zweiter Stelle der umsatzstärkste Pharmaunternehmen weltweit. Der Nettoumsatz 2013 belief sich auf 57,9 Milliarden Dollar. Novartis beschäftigte in 2013 über 135.000 Vollzeitmitarbeiter. Knapp die Hälfte davon (65.000) entfiel auf die Arzneimittelbranche. Die Ausgaben für Forschung & Entwicklung betrugen 9,9 Milliarden Dollar. Foto: Logo von Novartis Switzerland, Basel, 05.09.2014 Top 10 best-selling pharmaceutical companies worldwide The Swiss company Novartis last year was the world s second most profitable pharmaceutical companies. Net sales in 2013 amounted to 57.9 billion dollars. Novartis employed in 2013 over 135,000 full-time employees. Almost half of these (65,000) accounted for the drug industry. Spending on research and development am

    Unternehmen: Novartis Schweiz, Basel, 05.09.2014 Top 10 der umsatzstärksten Pharmaunternehmen weltweit Das Schweizer Unternehmen Novartis war im vergangenen Jahr an zweiter Stelle der umsatzstärkste Pharmaunternehmen weltweit. Der Nettoumsatz 2013 belief sich auf 57,9 Milliarden Dollar. Novartis beschäftigte in 2013 über 135.000 Vollzeitmitarbeiter. Knapp die Hälfte davon (65.000) entfiel auf die Arzneimittelbranche. Die Ausgaben für Forschung & Entwicklung betrugen 9,9 Milliarden Dollar. Foto: Logo von Novartis Switzerland, Basel, 05.09.2014 Top 10 best-selling pharmaceutical companies worldwide The Swiss company Novartis last year was the world s second most profitable pharmaceutical companies. Net sales in 2013 amounted to 57.9 billion dollars. Novartis employed in 2013 over 135,000 full-time employees. Almost half of these (65,000) accounted for the drug industry. Spending on research and development am

Collections